-
Global Life Science Leader[]BGI’s unparalleled understanding of its clients’ competitive landscape in conjunction with best-in-class executive through board level recruiting makes it the search firm of choice with clients that are truly focused on driving their success and bringing exceptional shareholder value.CEOBoardExecutiveLearn More
-
Global Life Science Leader[]BGI’s unparalleled understanding of its clients’ competitive
landscape in conjunction with best-in-class executive
through board level recruiting makes it the search firm
of choice with clients that are truly focused on driving
their success and bringing exceptional shareholder value.BiotechnologyPharmaceuticalMedical DeviceContract ServicesLearn More -
Global Life Science Leader[]BGI’s unparalleled understanding of its clients’ competitive
landscape in conjunction with best-in-class executive
through board level recruiting makes it the search firm
of choice with clients that are truly focused on driving
their success and bringing exceptional shareholder value.Saving LivesImproving TreatmentsLearn MoreMaximizing Shareholder ValueFinding CuresHelping Clients
Encompassing all Executive through Board Positions in Life Sciences
Director of the Board

Chief Executive Officer

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.
Chairman of the Board

Chief Financial Officer

Formerly Aastrom Biosciences
Chief Operating Officer

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company
Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.
In The News
Roche’s Lunsumio eyes year-end FDA verdict to be first bispecific for non-Hodgkin lymphoma aliu Wed, 07/06/2022 – 09:39
Viatris starts yet another insulin biosimilar recall over potential missing labels fkansteiner Wed, 07/06/2022 – 09:12
GSK’s consumer health spinoff Haleon will launch with ‘significant’ debt under its belt: report zbecker Tue, 07/05/2022 – 10:08
How Pfizer CEO Bourla’s evening call brought Biohaven back into the M&A fold aliu Tue, 07/05/2022 – 10:33
Roche, Pfizer and ViiV top patient groups’ views of leading pharmas for ESG work: Report badams Tue, 07/05/2022 – 09:22
Seagen touts new Tukysa colorectal cancer data, setting up FDA filing and a potential $500M opportunity zbecker Tue, 07/05/2022 – 11:16
Test 2
Virtual September 05-20
Test
Virtual August 03-16
Testing
Virtual July 08-20
Lorem ipsum
Virtual June 11-22
American Society of Hematology Annual Meeting and Exposition (ASH)
Atlanta/Virtual Hybrid December 11-14
Society for Neuro-Oncology Annual Meeting (SNO)
Boston, MA November 18-21